Immy

IMMY is a U.S.-based organization specializing in the development and distribution of innovative diagnostic tests and reagents for fungal diseases. With a mission to provide rapid and reliable access to fungal disease diagnoses globally, IMMY addresses the growing burden of fungal infections affecting over a billion people worldwide.

Focused on comprehensive diagnostics, IMMY offers a range of solutions including lateral flow assays, enzyme immunoassays, and polymerase chain reaction tests, all designed to enhance patient care and reduce antimicrobial resistance. Their products are tailored for both high-volume reference labs and smaller hospital settings, ensuring accurate and efficient testing for healthcare professionals.

Generated from the website